Strata Critical Medical, Inc. (SRTA)

Strata Critical Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	197.14	146.82	225.18	146.12	67.16
Revenue Growth (YoY)	34.28%	-34.80%	54.11%	117.58%	32.92%
Cost of Revenue	156.02	117.23	183.06	123.85	54.31
Gross Profit	41.13	29.59	42.12	22.28	12.85
Selling, General & Admin	60.88	50.86	105.61	70.26	42.96
Depreciation & Amortization Expenses	2.6	1.26	-	-	-
Research & Development	-	-	4.63	5.55	2.16
Total Operating Expenses	63.48	52.11	110.24	75.8	45.11
Operating Income	-22.35	-22.53	-68.12	-53.53	-32.26
Interest Income	4.24	7.21	8.44	3.43	0.74
Other Non-Operating Income (Expense)	-1.95	-0.85	2.13	22.06	-9.15
Total Non-Operating Income (Expense)	2.29	6.36	10.58	25.5	-8.41
Pretax Income	-20.07	-16.16	-57.54	-28.03	-40.67
Provision for Income Taxes	-	-	-1.47	-0.77	-3.75
Net Income	41.35	-27.31	-56.08	-27.26	-36.92
Earnings From Discontinued Operations	61.41	-11.15	-	-	-
Net Income to Common	41.35	-27.31	-56.08	-27.26	-36.92
Shares Outstanding (Basic)	82	77	74	71	34
Shares Outstanding (Diluted)	82	77	74	71	34
Shares Change (YoY)	5.93%	5.41%	3.21%	107.24%	-19.84%
EPS (Basic)	0.50	-0.35	0.55	-0.38	-1.07
EPS (Diluted)	0.50	-0.35	0.55	-0.38	-1.07
Free Cash Flow	-58.51	-33.38	-32.35	-37.86	-22.12
Free Cash Flow Per Share	-0.71	-0.43	-0.44	-0.53	-
Gross Margin	20.86%	20.15%	18.71%	15.24%	19.14%
Operating Margin	-11.34%	-15.34%	-30.25%	-36.63%	-48.04%
Profit Margin	-10.18%	-11.01%	-24.90%	-18.66%	-54.97%
FCF Margin	-29.68%	-22.74%	-14.37%	-25.91%	-32.93%
EBITDA	-14.17	-16.56	-61.01	-47.8	-31.09
EBITDA Margin	-7.19%	-11.28%	-27.09%	-32.72%	-46.29%
EBIT	-22.35	-22.53	-68.12	-53.53	-32.26
EBIT Margin	-11.34%	-15.34%	-30.25%	-36.63%	-48.04%
Effective Tax Rate	0.00%	0.00%	2.55%	2.75%	9.23%

Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q